Ocrevus receives conditional approval for use in early primary progressive MSIntravenous monoclonal antibody originally approved only for use in relapsing remitting multiple sclerosis (MS) Physicians develop recommendations for managing in-flight medical emergencies The OMA's balancing act: fixing the CANDI formula Contrave: new product for chronic weight management Naltrexone–bupropion combo approved as an adjunct to diet and exercise for obese or overweight adults Ottawa joins Brain Canada to create $10M grant for research platform Medication overuse headache: risk assessment and management CE: Managing seizure disorders in adults Viibryd: new antidepressant launches in Canada Vilazodone acts as a serotonin reuptake inhibitor and a partial agonist at 5-HT1A receptors CGRP antagonists: new migraine prevention therapies in current development Monoclonal antibodies targeting the calcitonin gene-related peptide pathway are under study for preventing episodic and chronic migraine Death of dementia patient stirs Belgium euthanasia fears After 15 years and 10,000 assisted deaths, just a single case in Belgium has been referred to prosecutors First Previous 126 127 128 129 130 Next Last
